A molecular taxonomy for urothelial carcinoma

Area of Science:

• Oncology
• Genomics
• Molecular Biology

Background:

• Urothelial carcinoma is a common male cancer with limited treatment advancements.
• Accurate tumor assessment is challenging in clinical practice, necessitating molecular biomarkers.
• Classifying tumors based on molecular features is an emerging strategy.

Purpose of the Study:

• To develop a molecular taxonomy for urothelial carcinoma using integrated genomics.
• To define distinct molecular subtypes of urothelial carcinoma.
• To explore the potential of molecular classification for improved patient outcomes and treatment selection.

Main Methods:

• Analysis of gene expression profiles from 308 urothelial carcinoma cases.
• Definition and validation of five major molecular subtypes using independent datasets.
• Validation of key gene expression at the protein level via immunohistochemistry.

Main Results:

• Five urothelial carcinoma subtypes identified: urobasal A, genomically unstable, urobasal B, squamous cell carcinoma like, and infiltrated.
• Subtypes exhibit distinct clinical outcomes and molecular profiles (gene expression, mutation frequency).
• Molecular subtypes are intrinsic tumor properties, independent of pathologic classification, and correlate with drug susceptibility.

Conclusions:

• The proposed molecular taxonomy provides a novel framework for classifying urothelial carcinoma.
• This classification has the potential to guide future clinical investigations and personalize treatment strategies.
• Molecular stratification may offer superior prediction of drug response compared to traditional pathologic classification.